Journey Medical Corp - Common Stock (DERM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
DERM on Nasdaq
Shares outstanding
17,194,910
Price per share
$7.71
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
8,692,790
Total reported value
$61,930,042
% of total 13F portfolios
0%
Share change
+2,197,263
Value change
+$15,659,236
Number of holders
67
Price from insider filings
$7.71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Journey Medical Corp - Common Stock (DERM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
WASATCH ADVISORS LP 6.7% +26% $7,972,248 +$1,532,476 1,152,059 +24% WASATCH ADVISORS LP 30 Jun 2025

As of 30 Sep 2025, 67 institutional investors reported holding 8,692,790 shares of Journey Medical Corp - Common Stock (DERM). This represents 51% of the company’s total 17,194,910 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Journey Medical Corp - Common Stock (DERM) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
TANG CAPITAL MANAGEMENT LLC 11% 1,854,596 0% 0.51% $13,204,724
WASATCH ADVISORS LP 7.6% 1,306,272 +13% 0.05% $9,300,657
Opaleye Management Inc. 5.6% 971,064 +922% 0.98% $6,913,976
BlackRock, Inc. 3.7% 633,059 +16% 0% $4,507,380
VANGUARD GROUP INC 3.6% 615,229 +8.9% 0% $4,380,431
Summit Financial, LLC 2.2% 379,829 0.04% $2,704,382
ESSEX INVESTMENT MANAGEMENT CO LLC 2.1% 354,021 +55% 0.39% $2,520,630
GEODE CAPITAL MANAGEMENT, LLC 1.6% 277,846 +5.9% 0% $1,978,435
RENAISSANCE TECHNOLOGIES LLC 1.4% 247,900 +1.8% 0% $1,765,048
Pale Fire Capital SE 1.3% 228,567 +604% 0.18% $1,627,397
AMERICAN FINANCIAL GROUP INC 1% 180,000 0% 0.49% $1,281,600
STATE STREET CORP 0.85% 146,037 +27% 0% $1,039,783
UBS Group AG 0.84% 145,220 -8.5% 0% $1,033,966
PVG ASSET MANAGEMENT CORP 0.77% 132,904 -11% 3.5% $946,276
Sheets Smith Investment Management 0.77% 132,904 0.61% $946,276
Legato Capital Management LLC 0.59% 101,896 +50% 0.08% $725,500
NORTHERN TRUST CORP 0.54% 92,742 +9.1% 0% $660,323
Informed Momentum Co LLC 0.52% 89,389 -6% 0.07% $636,450
Geneos Wealth Management Inc. 0.37% 63,280 0% 0.01% $450,554
ENVESTNET ASSET MANAGEMENT INC 0.35% 60,950 -13% 0% $433,964
AQR CAPITAL MANAGEMENT LLC 0.3% 50,834 0% $361,938
Creative Planning 0.29% 50,500 +54% 0% $359,560
Integrated Wealth Concepts LLC 0.26% 44,350 -20% 0% $315,772
STATE OF WISCONSIN INVESTMENT BOARD 0.21% 35,838 0% $255,167
GOLDMAN SACHS GROUP INC 0.2% 34,053 0% $242,457

Institutional Holders of Journey Medical Corp - Common Stock (DERM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 29,482 $227,306 +$17,101 $7.71 3
2025 Q3 8,692,790 $61,930,042 +$15,659,236 $7.12 67
2025 Q2 6,494,302 $46,629,314 +$11,145,137 $7.18 56
2025 Q1 5,017,760 $29,603,817 +$7,390,927 $5.90 38
2024 Q4 3,813,405 $14,909,751 +$6,149,987 $3.91 38
2024 Q3 2,156,982 $12,186,357 -$1,194,242 $5.65 36
2024 Q2 2,360,259 $13,310,203 +$3,384,583 $5.64 35
2024 Q1 1,816,385 $6,678,973 +$973,921 $3.68 31
2023 Q4 1,341,390 $7,982,763 -$492,957 $5.76 34
2023 Q3 2,135,266 $5,850,655 +$1,401,524 $2.74 20
2023 Q2 1,652,825 $2,627,537 -$24,753 $1.59 19
2023 Q1 1,668,350 $2,620,320 -$179,207 $1.57 16
2022 Q4 2,672,478 $5,131,893 -$313,986 $1.92 18
2022 Q3 1,878,524 $4,621,000 +$328,580 $2.46 18
2022 Q2 1,759,431 $6,580,100 +$289,703 $3.74 12
2022 Q1 1,644,289 $7,940,000 +$35,914 $4.83 13
2021 Q4 1,627,492 $8,756,000 +$8,756,000 $5.38 14